| Filed | Form | Description | |
|---|---|---|---|
| 5/23/25 | DEFA14A | DEFA14A | → |
| 4/28/25 | DEFA14A | DEFA14A | → |
| 4/28/25 | DEF 14A | DEF 14A | → |
| 4/18/25 | PRE 14A | PRE 14A | → |
| 6/11/24 | DEFA14A | DEFA14A | → |
| 5/28/24 | DEFA14A | DEFA14A | → |
| ↓ | |||
| Filed | Form | Description | |
|---|---|---|---|
| 12/10/25 | 4 | 4 | → |
| 12/10/25 | 4 | 4 | → |
| 12/10/25 | 4 | 4 | → |
| 12/10/25 | 4 | 4 | → |
| 12/10/25 | 4 | 4 | → |
| 12/10/25 | 4 | 4 | → |
| ↓ | |||
Adverum Biotechnologies, Inc. is a publicly traded clinical stage gene therapy company located in Redwood City, California.